Registration link below for Wednesday March 18, 2026 at 4 PM EDT Phio invites individual and institutional investors, as well ...

A wanted criminal and his accomplice were arrested by the Navi Mumbai Police for allegedly selling narcotic substances under the guise of running a goat farm ...

Add Yahoo as a preferred source to see more of our stories on Google. ASHTABULA — High school students from A-Tech, Grand Valley Local Schools and Conneaut Area City Schools gathered at the Kent State ...

Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...

Sanjay Upadhyay, BJP MLA from Borivali, told the Maharashtra Assembly that acres of mangroves have been destroyed ...

A month has gone by since the last earnings report for Incyte (INCY). Shares have lost about 4.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to ...

Fred Hutch Cancer Center medical oncologist Dr. Lisa Tachiki has been named a 2025 Cancer Research Fellow by the Kuni Foundation, an honor that includes an unrestricted, two-year $300,000 award.

Barclays 28th Annual Global Healthcare Conference March 11, 2026 9:30 AM EDTCompany ParticipantsSara Pellegrino ...

The U.S. Food and Drug Administration (FDA) declined approval of retifanlimab-dlwr for patients with metastatic non-small cell lung cancer (NSCLC) in the United States because of manufacturing ...

In a second EU approval today, Johnson & Johnson got a green light for Akeega (niraparib and abiraterone acetate) for the ...

Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did ...

Incyte said on Friday that the European Commission has approved its Zynyz for yet another rare cancer, marking the drug’s second approval in the region. The company said that the commission approved ...